Tigecycline Patent Expiration
Tigecycline was first introduced by Pf Prism Cv
Tigecycline Patents
Given below is the list of patents protecting Tigecycline, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Tigecycline | US9855335 | Tigecycline composition for injection | Apr 07, 2033 | Amneal |
Tigecycline | US9855355 | Method and device for plasma-treating hollow bodies | Apr 07, 2033 | Amneal |
Tygacil | US8372995 | Crystalline solid forms of tigecycline and methods of preparing same | Oct 08, 2030 | Pf Prism Cv |
Tygacil | US7879828 | Tigecycline compositions and methods of preparation | Feb 05, 2029 | Pf Prism Cv |
Tygacil | US8975242 | Tigecycline compositions and methods of preparation | Oct 24, 2028 | Pf Prism Cv |
Tygacil | US10588975 | Tigecycline compositions and methods of preparation | Mar 13, 2026 | Pf Prism Cv |
Tygacil | US9254328 | Tigecycline compositions and methods of preparation | Mar 13, 2026 | Pf Prism Cv |
Tygacil | US9694078 | Tigecycline compositions and methods of preparation | Mar 13, 2026 | Pf Prism Cv |
Tygacil | USRE40183 | 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
Apr 09, 2016
(Expired) | Pf Prism Cv |
Tygacil | USRE40086 | Method for treating bacterial infection with novel 7-substituted-9-substituted amino 6-demethyl-6-deoxytetracyclines |
Jun 25, 2013
(Expired) | Pf Prism Cv |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Tigecycline's patents.
Latest Legal Activities on Tigecycline's Patents
Given below is the list recent legal activities going on the following patents of Tigecycline.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Payment of Maintenance Fee, 12th Year, Large Entity | 11 Jul, 2024 | US8372995(Litigated) |
Payment of Maintenance Fee, 4th Year, Large Entity | 10 Aug, 2023 | US10588975 |
Payment of Maintenance Fee, 8th Year, Large Entity | 13 Jul, 2023 | US9254328 |
Payment of Maintenance Fee, 8th Year, Large Entity | 10 Aug, 2022 | US8975242(Litigated) |
Payment of Maintenance Fee, 12th Year, Large Entity | 13 Jul, 2022 | US7879828(Litigated) |
Expire Patent Critical
| 07 Feb, 2022 | US9855355 |
Maintenance Fee Reminder Mailed Critical
| 23 Aug, 2021 | US9855355 |
Payment of Maintenance Fee, 4th Yr, Small Entity | 07 Jul, 2021 | US9855335 |
Surcharge for late Payment, Small Entity | 07 Jul, 2021 | US9855335 |
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 11 Jun, 2021 | US9855335 |
Tigecycline's Family Patents
